Data / Form D filings / Balto Pharmaceuticals, Inc.
Balto Pharmaceuticals, Inc.: Form D filing
Balto Pharmaceuticals, Inc., a pharmaceuticals company in South Pasadena, CA, filed a Form D with the SEC in 2023. The latest, on September 14, 2023, reports $2 million sold of a $2 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 99 PASADENA AVENUE, SUITE 5, South Pasadena, CA, 91030
- Phone
- (626) 678-3368
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- California
- Revenue range
- Not Applicable
- Exemptions claimed
- Rule 504, Rule 506(b)
- SEC identifier (CIK)
- 1993350
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 14, 2023 | New notice | $2,000,000 | $2,000,000 | 2 | Aug 22, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Chanxing Wilson Xu | Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Sep 11, 2023 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Balto Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.